Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-03

Clinical Trial Update: Special Drug Use-results Survey for Long-term Use (Fostamatinib)

View source ↗

Summary

A long-term use results survey for fostamatinib in chronic idiopathic thrombocytopenic purpura is being conducted, with the study currently recruiting. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fostamatinib (fostamatinib)

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Chronic Idiopathic Thrombocytopenic Purpura | Status: RECRUITING